Target intelligence / Profile preview

Wound bed stromal and parenchymal cells

Molecular classification
Other
01

Overview

Wound bed stromal and parenchymal cells encompass the diverse cellular components essential for the physiological process of tissue repair following injury. Stromal cells, including fibroblasts, pericytes, and endothelial cells, form the supportive framework and vasculature, while parenchymal cells, such as keratinocytes in the epidermis, perform the primary functional roles of the tissue (Gurtner et al., 2008, Nature [https://www.nature.com/articles/nature07039]). These cells are not a single molecular target but rather a coordinated biological system that responds to various therapeutic interventions, such as growth factors and specialized dressings, to facilitate wound closure (Werner & Grose, 2003, Physiological Reviews [https://journals.physiology.org/doi/full/10.1152/physrev.00031.2002]). In chronic conditions like diabetic ulcers, the dysfunction of these cells—characterized by impaired migration and excessive senescence—leads to healing arrest (Velnar et al., 2009, Journal of International Medical Research [https://journals.sagepub.com/doi/10.1177/147323000903700531]). Therapeutic strategies often aim to stimulate these cells using agents like Becaplermin, which mimics endogenous signaling to promote proliferation and extracellular matrix deposition (Papanas & Maltezos, 2007, Clinical Interventions in Aging [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684071/]). Understanding the interplay between these cell types is crucial for developing treatments for both non-healing wounds and fibroproliferative disorders.

Other names
Wound bed cellsWound environment cellsStromal-parenchymal cell complexWound tissue cells
02

Mechanism of action

Stimulation of cellular proliferation, migration, and extracellular matrix production through growth factor signaling and enzymatic debridement of necrotic tissue.

03

Biological functions

Wound healingTissue regenerationExtracellular matrix synthesisAngiogenesisCell proliferationInflammation modulation
04

Disease associations

Chronic woundsDiabetic foot ulcerFibrosisHypertrophic scarringVenous leg ulcers
05

Safety considerations

Risk of malignancy with prolonged growth factor useExcessive scarring or keloid formationHypersensitivity reactionsInfection risk if barrier function is not restoredSystemic absorption of topical agents
06

Interacting drugs

Becaplermin

4 more in the full profile.

07

Biomarkers

Alpha-smooth muscle actin (α-SMA)VimentinCytokeratinCD31Matrix metalloproteinase-9 (MMP-9)

Beyond the preview

Go deeper on Wound bed stromal and parenchymal cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wound bed stromal and parenchymal cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call